(154) found that patients with very early-onset IBD who have NOD2 polymorphisms (NOD2+) were substantially more likely than those in the NOD2 group to have arthropathy (60%) and a CD-like phenotype (90%), as well as linear growth impairment (90%).Horowitz et al. The gene discussed is NOD2; the disease is inflammatory bowel disease.